Jerry C. Cheng

947 total citations
28 papers, 707 citations indexed

About

Jerry C. Cheng is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Jerry C. Cheng has authored 28 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 8 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Jerry C. Cheng's work include Acute Myeloid Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (4 papers) and Virus-based gene therapy research (3 papers). Jerry C. Cheng is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (4 papers) and Virus-based gene therapy research (3 papers). Jerry C. Cheng collaborates with scholars based in United States, India and France. Jerry C. Cheng's co-authors include Kathleen M. Sakamoto, Deepa Shankar, Theodore B. Moore, Elliot M. Landaw, Kentaro Kinjo, Noah Federman, Nagesh Rao, Amandip S. Gill, Dejah R. Judelson and Ingrid Schmid and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Cell.

In The Last Decade

Jerry C. Cheng

26 papers receiving 697 citations

Peers

Countries citing papers authored by Jerry C. Cheng

Since Specialization

Citations

This map shows the geographic impact of Jerry C. Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerry C. Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerry C. Cheng more than expected).

Fields of papers citing papers by Jerry C. Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerry C. Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerry C. Cheng. The network helps show where Jerry C. Cheng may publish in the future.

Co-authorship network of co-authors of Jerry C. Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Jerry C. Cheng. A scholar is included among the top collaborators of Jerry C. Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerry C. Cheng. Jerry C. Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genomic insights of two Acinetobacter non-baumannii strains with uncommon mechanisms of resistance leading to cefiderocol resistance 2025 ·Infection Genetics and Evolution ·(unknown), (unknown), (unknown), Juan Pablo Gutiérrez, Fernando Pasterán, Marisel R. Tuttobene, (unknown), Jerry C. Cheng, (unknown), Rajnikant Sharma, Marcelo E. Tolmasky, Gauri G. Rao, Robert A. Bonomo, Germán M. Traglia, María Soledad	0
2	Autism Screening Using the Parent's Observation of Social Interactions in a Large Integrated Healthcare System 2024 ·The Journal of Pediatrics ·Kek Khee Loo, (unknown), Jerry C. Cheng	1
3	Treatment of post‐transplant lymphoproliferative disorder (PTLD) in a heart transplant recipient with chimeric antigen receptor T‐cell therapy 2020 ·Pediatric Transplantation ·(unknown), James Ch’ng, Matthew Russell, Jerry C. Cheng, Theodore B. Moore, Juan Alejos	20
4	Long-Term Follow-up of High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Children and Young Adults with Metastatic or Relapsed Ewing Sarcoma: A Single-Institution Experience 2020 ·Transplantation and Cellular Therapy ·Anna Pawłowska, (unknown), George T. Calvert, Nicole Karras, Judith K. Sato, (unknown), Jerry C. Cheng, (unknown), (unknown), (unknown), Dongyun Yang, Andrew Dagis, James S. Miser, Joseph Rosenthal	2
5	HLA-Haploidentical Stem Cell Transplant with Pre-Transplant Immunosuppression for Patients with Sickle Cell Disease 2017 ·Blood ·Anna Pawłowska, Nicole Karras, Jerry C. Cheng, Weili Sun, Leo D. Wang, (unknown), (unknown), Joseph Rosenthal	1
6	HLA Haploidentical Stem Cell Transplant with Pretransplant Immunosuppression for Patients with Sickle Cell Disease 2017 ·Biology of Blood and Marrow Transplantation ·Anna Pawłowska, Jerry C. Cheng, Nicole Karras, Weili Sun, Leo D. Wang, (unknown), (unknown), Joseph Rosenthal	35
7	Development of Care Pathway to Ensure Timely and Appropriate Re-Vaccination in Pediatric Survivors of Stem Cell Transplant (SCT) 2017 ·Biology of Blood and Marrow Transplantation ·Jerry C. Cheng, (unknown), (unknown)	2
8	High Dose Chemotherapy (HDT) with Busulfan, Melphalan and Topotecan Followed by Autologous Hematopoietic Stem Cell Transplantation (ASCT) in Pediatric Patients (pts) with High Risk Solid Tumors 2012 ·Biology of Blood and Marrow Transplantation ·Anna Pawłowska, Julie Wolfson, Jerry C. Cheng, April Sorrell, Judith K. Sato, Craig S. Anderson, (unknown), (unknown), Stephen J. Forman, Joseph Rosenthal	3
9	Outcome of Second Allogeneic Stem Cell Transplantation (SCT) in Pediatric Patients With Graft Failure or Recurrent Leukemia 2011 ·Biology of Blood and Marrow Transplantation ·Anna Pawłowska, Jerry C. Cheng, Tracey Stiller, Joycelynne Palmer, (unknown), Joseph Rosenthal	0
10	Rosette-forming glioneuronal tumor: a pineal region case with IDH1 and IDH2 mutation analyses and literature review of 43 cases 2010 ·Journal of Neuro-Oncology ·Orestes E. Solis, Rupal I. Mehta, Albert Lai, Rashi I. Mehta, (unknown), Richard M. Green, Jerry C. Cheng, Sathima Natarajan, Harry V. Vinters, Timothy F. Cloughesy, William H. Yong	63
11	Expression profile of CREB knockdown in myeloid leukemia cells 2008 ·BMC Cancer ·Matteo Pellegrini, Jerry C. Cheng, Jon Voutila, Dejah R. Judelson, Julie Taylor, Stanley F. Nelson, Kathleen M. Sakamoto	29
12	Potential Role of Creb As A Prognostic Marker In Acute Myeloid Leukemia 2007 ·Future Oncology ·Jerry C. Cheng, (unknown), Salemiz Sandoval, Deepa Shankar, Cecilia Fu, Kathleen M. Sakamoto	19
13	Topics in pediatric leukemia--acute myeloid leukemia. 2005 ·PubMed Central ·Jerry C. Cheng, (unknown)	6
14	The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia 2005 ·Cancer Cell ·Deepa Shankar, Jerry C. Cheng, Kentaro Kinjo, Noah Federman, Theodore B. Moore, Amandip S. Gill, Nagesh Rao, Elliot M. Landaw, Kathleen M. Sakamoto	199
15	Improved Documentation of Wound Care With a Structured Encounter Form in the Pediatric Emergency Department 2005 ·Ambulatory Pediatrics ·John T. Kanegaye, Jerry C. Cheng, (unknown), (unknown), Patricia D. Silva	17
16	Role of cyclic AMP response element binding protein in human leukemias 2005 ·Cancer ·Deepa Shankar, Jerry C. Cheng, Kathleen M. Sakamoto	46
17	Induction of neuropeptide gene expression and blockade of retrograde transport in facial motor neurons following local peripheral nerve inflammation in severe combined immunodeficiency and BALB/C mice 2004 ·Neuroscience ·Brian Armstrong, Zhong-Ting Hu, Catalina Abad, (unknown), Williams I. Rodriguez, Jerry C. Cheng, (unknown), (unknown), Rosa P. Gomariz, James A. Waschek	26
18	The Emerging Role of RNA Interference in the Design of Novel Therapeutics in Oncology 2004 ·Cell Cycle ·Jerry C. Cheng, Kathleen M. Sakamoto	7
19	Severe Lactic Acidosis in a 14-Year-Old Female With Metastatic Undifferentiated Carcinoma of Unknown Primary 2004 ·Journal of Pediatric Hematology/Oncology ·Jerry C. Cheng, (unknown), (unknown), Kathleen M. Sakamoto, Theodore B. Moore	13
20	RNA interference and human disease 2003 ·Molecular Genetics and Metabolism ·Jerry C. Cheng, Theodore B. Moore, Kathleen M. Sakamoto	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact